GRP78, the central regulatory molecule of UPR, can activate UPR to reduce or stop ERS, so as to stabilize the homeostasis of cancer cells and exert an important role in UPR regulation, cell survival, proliferation and migration [31–33]. Here, HSPA5 is linked to cancer.